GlassScriptPhysician profile
Brad Oriel
NPI 1760776124
$2,061.26
in general payments reported to CMS, 2019-2025
16 companies · $660 in 2025
The $660 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $38.84 · 2021: $55.26 · 2022: $41.91 · 2023: $304 · 2024: $646 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,610.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $386.33 | 2019-2025 | |
| Silk Road Medical, INC. | $324.26 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $223.17 | 2020-2024 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin |
| Bard Peripheral Vascular, INC. | $197.81 | 2024-2025 | Rotarexs 6 F X 135 Cm, Lifestream |
| Medtronic Vascular, INC. | $171.18 | 2019 | |
| Boston Scientific Corporation | $163.47 | 2024-2025 | Eluvia, Varithena Administration Pack |
| Medtronic, INC. | $150.17 | 2023-2025 | Turbohawk, Spiderfx, Venaseal |
| Bolton Medical INC | $147.47 | 2024 | Treo Abdominal Stent-Graft System |
| Cook Medical LLC | $84.33 | 2025 | Lunderquist, Zilver Ptx |
| Veryan Medical Incorporated | $59.68 | 2025 | Biomimics 3d Vascular Stent System |
| Philips North America LLC | $46.34 | 2024-2025 | (Br5) Peripheral Ivus, Peripheral Vascular Undivided |
| Lemaitre Vascular, INC. | $37.53 | 2025 | Artegraft Vascular Graft |
| Cordis US Corp. | $22.56 | 2025 | Mynx Control Venous |
| Ossur Americas, INC. | $20.60 | 2025 | |
| Sanara Medtech INC. | $20.50 | 2025 | Celleraterx |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $5.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Oriel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.